Vijaya Diagnostic Centre Limited has informed the Exchange about Investor Presentation
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre shared its Q4 & FY25 earnings presentation ahead of the investor call. FY25 revenue grew 24.4% YoY to ₹6,814 Mn, EBITDA rose 23.7% to ₹2,732 Mn (40.1% margin), and PAT increased 20.4% to ₹1,431 Mn (21.0% margin). Q4 FY25 revenue stood at ₹1,732 Mn, up 11.6% YoY, with EBITDA at ₹689 Mn (39.8% margin) and PAT at ₹346 Mn (20.0% margin). The company added 6 new hubs in Pune, West Bengal, and Bengaluru over the past 2 months and plans to open 10 more hubs and 3 spokes in FY26. Footfalls grew 18% to 4.19 Mn and tests grew 24.4% to 14.79 Mn in FY25.
Strong full-year growth with healthy margins and aggressive hub expansion signals confidence in scaling across new geographies. Slight margin compression in Q4 and increased capex on new hubs may weigh on near-term margins, but the expansion pipeline supports future revenue growth.